Swiss - Delayed Quote CHF

Evolva Holding SA (EVE.SW)

Compare
1.1000
-0.0650
(-5.58%)
At close: January 10 at 5:30:32 PM GMT+1
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,437.8000
9,437.8000
15,539.4000
9,877.6000
7,540.7000
Cost of Revenue
12,020.4000
12,020.4000
21,548.0000
19,183.5000
9,782.4000
Gross Profit
-2,582.6000
-2,582.6000
-6,008.6000
-9,305.9000
-2,241.7000
Operating Expense
47,782.0000
47,782.0000
34,383.4000
32,723.6000
22,663.0000
Operating Income
-50,364.6000
-50,364.6000
-40,392.0000
-42,029.5000
-24,904.7000
Net Non Operating Interest Income Expense
-2,283.6000
-2,283.6000
-683.9000
-932.2000
-1,046.0000
Pretax Income
-105,229.4000
-105,229.4000
-43,366.4000
-41,407.5000
-29,882.2000
Tax Provision
--
--
--
-141.1000
-18.0000
Net Income Common Stockholders
-105,229.4000
-105,229.4000
-43,366.4000
-41,266.4000
-29,870.2000
Diluted NI Available to Com Stockholders
-105,229.4000
-105,229.4000
-43,366.4000
-41,266.4000
-29,870.2000
Basic EPS
-19.50
-19.50
-10.00
-12.50
-10.00
Diluted EPS
-19.50
-19.50
-10.00
-12.50
-10.00
Basic Average Shares
5,396.3000
5,396.3000
4,281.2170
3,519.6020
3,147.2080
Diluted Average Shares
5,396.3000
5,396.3000
4,281.2170
3,519.6020
3,147.2080
Total Operating Income as Reported
-92,245.3000
-92,245.3000
-40,392.1000
-42,029.5000
-24,904.7000
Total Expenses
59,802.4000
59,802.4000
55,931.4000
51,907.1000
32,445.4000
Net Income from Continuing & Discontinued Operation
-105,229.4000
-105,229.4000
-43,366.4000
-41,266.4000
-29,870.2000
Normalized Income
-48,664.1000
-48,664.1000
-44,027.1000
-41,189.0328
-29,870.2000
Interest Income
7.2000
7.2000
76.8000
50.7000
67.2000
Interest Expense
2,290.8000
2,290.8000
760.7000
982.9000
1,113.2000
Net Interest Income
-2,283.6000
-2,283.6000
-683.9000
-932.2000
-1,046.0000
EBIT
-102,938.6000
-102,938.6000
-42,605.7000
-40,424.6000
-28,769.0000
EBITDA
-98,357.4000
-98,357.4000
-34,517.0000
-31,819.9000
-20,597.1000
Reconciled Cost of Revenue
12,020.4000
12,020.4000
21,548.0000
19,183.5000
9,782.4000
Reconciled Depreciation
4,581.2000
4,581.2000
8,088.7000
8,604.7000
8,171.9000
Net Income from Continuing Operation Net Minority Interest
-105,229.4000
-105,229.4000
-43,366.4000
-41,266.4000
-29,870.2000
Total Unusual Items Excluding Goodwill
-56,565.3000
-56,565.3000
660.7000
-77.6000
--
Total Unusual Items
-56,565.3000
-56,565.3000
660.7000
-77.6000
--
Normalized EBITDA
-41,792.1000
-41,792.1000
-35,177.7000
-31,742.3000
-20,597.1000
Tax Rate for Calcs
--
--
--
0.0000
0.0000
Tax Effect of Unusual Items
--
--
--
-0.2328
--
12/31/2020 - 5/3/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
 
5KW.F SkinBioTherapeutics plc
0.1720
+1.18%
 
7IZ.MU Ziccum AB
0.0298
-29.72%
 
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%
 
4AJ0.SG Alk-Abello A/S
19.46
+0.46%
 
41X.F Ardelyx, Inc.
5.12
+0.16%
 
PH4.F CStone Pharmaceuticals
0.2640
-1.49%
 
XRP2.F Silence Therapeutics plc
5.95
+0.85%
 
BLE.BE bluebird bio Inc
0.3708
-3.01%
 
SPEX.SW Spexis AG
0.0570
0.00%